There are a lot of reasons why people are motivated to do scientific research, with sheer curiosity about the natural world ...

In this month's edition of The LCGC Blog, Andre Striegel discusses where macromolecular scientists around the world can ...

Nomura Holdings, Inc. ( NYSE: NMR) Q4 2025 Earnings Call Transcript April 25, 2025 5:30 AM ET Masao Muraki - SMBC Nikko Securities Kazuki Watanabe - Daiwa Securities Natsumu Tsujino - BofA Securities ...

The device helps identify NSCLC subjects who are likely to benefit from Daiichi Sankyo and AstraZeneca’s Datroway’s treatment ...

The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis and digital pathology ...

US FDA grants breakthrough device designation to Roche’s companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer: Basel Wednesday, April 30, 20 ...

RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment. The device uses artificial intelligence-based image analysis with a level ...

It seems advisers are like a box of chocolates when it comes to greenwashing: you never know what you are going to get.

The tumor microenvironment is a harsh environment where metabolic adaptations are key. In this article, we explore how the ...

RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment. The device uses artificial intelligence-based ...

Q1 2025 Earnings Conference Call April 29, 2025 6:45 AM ETCompany ParticipantsAndy Barnett - Head of IRPascal Soriot ...

The first AI-powered companion diagnostic for non-small cell lung cancer has received FDA Breakthrough Device Designation.